UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas Journal article
Li, Ping, Chen, Fengyang, Zheng, Jingbin, Yang, Yang, Li, Yuan, Wang, Yifei, Chen, Xin*. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas[J]. Cancer Biology and Medicine, 2021, 18(4), 1010-1020.
Authors:  Li, Ping;  Chen, Fengyang;  Zheng, Jingbin;  Yang, Yang;  Li, Yuan; et al.
Favorite | TC[WOS]:8 TC[Scopus]:7  IF:5.6/5.9 | Submit date:2021/12/08
Bleomycin  Cyclophosphamide  Tnfr2  Tregs  Tumor Necrosis Factor  
Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway Journal article
Li,Ao, Xiao,Xiao, Feng,Zhe Ling, Chen,Xiuping, Liu,Li Juan, Lin,Li Gen, Lu,Jin Jian, Zhang,Le Le. Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway[J]. Toxicology and Applied Pharmacology, 2020, 389, 114882.
Authors:  Li,Ao;  Xiao,Xiao;  Feng,Zhe Ling;  Chen,Xiuping;  Liu,Li Juan; et al.
Favorite | TC[WOS]:19 TC[Scopus]:20  IF:3.3/3.6 | Submit date:2021/03/01
Bleomycin  Fibrotic Process  Nagilactone d  Pulmonary Fibrosis  Tgf-β1  
Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury Journal article
He M., Cheng N., Gao W.-W., Zhang M., Zhang Y.-Y., Ye R.D., Wang M.-W.. Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury[J]. Acta Pharmacologica Sinica, 2011, 32(5), 601-610.
Authors:  He M.;  Cheng N.;  Gao W.-W.;  Zhang M.;  Zhang Y.-Y.; et al.
Favorite | TC[WOS]:32 TC[Scopus]:33 | Submit date:2018/11/07
Anti-inflammation  Bleomycin  Cytokines  Formyl Peptide Receptor  Lung Injury  Quin-c1